Grants and Contributions:
Title:
Configurable optimization engine for pharmaceutical production
Agreement Number:
1028825
Agreement Value:
$400,000.00
Agreement Date:
Mar 3, 2025 - Dec 18, 2026
Description:
The project aims to develop a digital twin to optimize pharmaceutical production processes. This advancement will improve the resilience and adaptability of Canada’s drug manufacturing chains.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H3M 1W2
Reference Number:
172-2024-2025-Q4-1028825
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
747605301
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 340 days. The total amended value is 150,000 dollars.
Amendment Date
Nov 6, 2025
Recipient's Legal Name:
Kaster Technologies Inc
Federal Riding Name:
Ahuntsic-Cartierville
Federal Riding Number:
24003
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211
Amendments: